NASDAQ: INMB
Inmune Bio Inc Stock Ownership - Who owns Inmune Bio?

Insider buying vs selling

Have Inmune Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when INMB insiders and whales buy or sell their stock.

INMB Shareholders

What type of owners hold Inmune Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Xencor Inc7.09%1,885,533$2.28MInsider
Raymond Joseph Tesi5.85%1,554,106$1.88MInsider
Mark William Lowdell5.68%1,510,806$1.83MInsider
David J. Moss4.84%1,285,869$1.56MInsider
Blackrock Inc4.56%1,212,100$1.47MInstitution
Vanguard Group Inc3.60%957,846$1.16MInstitution
Linda F. Powers3.42%910,000$1.10MInsider
Geode Capital Management LLC1.66%441,650$534.40kInstitution
State Street Corp1.31%347,259$420.18kInstitution
Dauntless Investment Group LLC1.15%304,922$368.96kInstitution

1 of 3

INMB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INMB19.12%27.83%
BTAI1.76%98.24%
DYAI9.58%90.42%Net Buying
EVAX0.34%3.87%
PTN4.34%95.66%Net Buying

Inmune Bio Stock Ownership FAQ

Who owns Inmune Bio?

Inmune Bio (NASDAQ: INMB) is owned by 19.12% institutional shareholders, 27.83% Inmune Bio insiders, and 53.05% retail investors. Xencor Inc is the largest individual Inmune Bio shareholder, owning 1.89M shares representing 7.09% of the company. Xencor Inc's Inmune Bio shares are currently valued at $2.28M.

If you're new to stock investing, here's how to buy Inmune Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.